Legal status · United Kingdom
Is Dasatinib legal in the United Kingdom?
Yes. Dasatinib is an approved medicine in the United Kingdom, classified as "Licensed (for its labeled use), prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Dasatinib in the United Kingdom at a glance
| Classification | Licensed (for its labeled use), prescription only |
|---|---|
| MHRA approval status | Approved by MHRA for its labeled use |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Dasatinib profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
MHRA has approved Dasatinib for at least one labeled indication, so a pharmaceutical-grade product exists in the United Kingdom and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Dasatinib is
An FDA-approved leukemia drug repurposed in research as a senolytic, most often combined with quercetin to clear senescent cells.
Dasatinib is a kinase inhibitor approved as Sprycel for certain leukemias. In longevity research it is repurposed as a senolytic, clearing senescent cells, and is studied in the 'D+Q' combination with quercetin for conditions linked to cellular aging such as diabetic kidney disease and lung fibrosis.
Mechanism: Inhibits survival signaling in senescent cells, triggering their death, especially alongside quercetin.
Regulatory history: FDA-approved for leukemia; senolytic use is off-label and investigational
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Dasatinib at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Dasatinib in other countries
United States
Approved medicineFDA-approved (for its labeled use), prescription only
Is Dasatinib legal in the United States?Australia
Approved medicineTGA-registered (for its labeled use), prescription only
Is Dasatinib legal in Australia?Canada
Approved medicineHealth Canada approved (for its labeled use), prescription only
Is Dasatinib legal in Canada?Frequently asked questions
Is Dasatinib legal in the United Kingdom?
Yes. Dasatinib is an approved medicine in the United Kingdom, classified as "Licensed (for its labeled use), prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Can I buy Dasatinib in the United Kingdom?
Only with a prescription. Dasatinib is classified as "Licensed (for its labeled use), prescription only" in the United Kingdom, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Dasatinib MHRA approved?
Yes, for its labeled indication. In the United Kingdom Dasatinib is classified as "Licensed (for its labeled use), prescription only". For comparison, the US FDA status is: FDA-approved for leukemia; senolytic use is off-label and investigational. Evidence level: Preliminary.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Dasatinib live on its compound profile.
Dasatinib profileThis page is general information about the regulatory status of Dasatinib in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.